Exhibit 23.2

​

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the Registration Statement on Form S-1 of Kiromic BioPharma, Inc. and subsidiaries of our report dated April 17, 2023 relating to the consolidated financial statements appearing in the Annual Report on Form 10-K of Kiromic BioPharma, Inc. for the year ended December 31, 2022.

​

/s/ Whitley Penn LLP

​

Houston, Texas

May 15, 2023